White Paper
Pharma Manufacturing: Attaining the Right Global Mix
![Pharma Manufacturing: Attaining the Right Global Mix](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_product_file/publications/pharmaceutical-science/outsourcing-pharma.com/resources/contract-manufacturing/pharma-manufacturing-attaining-the-right-global-mix/12358528-1-eng-GB/Pharma-Manufacturing-Attaining-the-Right-Global-Mix.jpg)
The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links & re-igniting discussions around the value of reshoring production. The U.S. FDA reports 72% of facilities manufacturing APIs for American drugs are overseas, with 13% in China. Download our white paper where we discuss effective strategies to secure and de-risk pharmaceutical supply chains & reveal how AMRI assures the continual production of urgently needed drugs.